Copy Link Print Information

Agazisiran

Agazisiran, a siRNA,is a complement factor B synthesis reducer.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • CAS No.: 2985646-78-2
  • Formule: C534H706F15N179O329P44S8
  • Masse moléculaire:16800.60
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Agazisiran Chemical Structure
    Agazisiran Chemical Structure
CAS No.: 2985646-78-2
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Agazisiran Chemical Structure
    Agazisiran Chemical Structure RNA, ([3'-O-[2-[[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]-2'-O-[2-[bis[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]]U-(5'→5')-sp-Gm-sp-Gm-Am-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-Gm-Gm-Am-Um-Gm-Um-Cm-Um-sp-Am-(3'→3')-sp-[1'-de(6-amino-9H-purin-9-yl)]A), complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)U-sp-Cm-sp-Cm) (1:1)
    1/16
  • RNA, ([3'-O-[2-[[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]-2'-O-[2-[bis[[1-[17-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-3,6,9,12,15-pentaoxaheptadec-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-2-oxoethyl]]U-(5'→5')-sp-Gm-sp-Gm-Am-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-Gm-Gm-Am-Um-Gm-Um-Cm-Um-sp-Am-(3'→3')-sp-[1'-de(6-amino-9H-purin-9-yl)]A), complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)U-sp-Cm-sp-Cm) (1:1)